Market closedNon-fractional
Zomedica/ZOM
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About Zomedica
Zomedica Corp is a veterinary health company creating products for companion animals (canine, feline and equine) by focusing on the unmet needs of clinical veterinarians. The company's product portfolio includes diagnostics and therapeutics that emphasize patient health and practice health. The company is focused on the final development and commercialization of its TRUFORMA platform, which detects thyroid disorders in dogs & cats and adrenal disorders in dogs. Its operations are comprised of two reportable segments namely Diagnostic and Therapeutic Devices. It earns the majority of revenue from the therapeutics segment.
Ticker
ZOM
Sector
Healthcare
Trading on
AMEX
Industry
Health Care Equipment and Supplies
Headquarters
Ann Arbor, United States
Employees
144
Website
www.zomedica.com
Zomedica Metrics
BasicAdvanced
$150M
Market cap
-
P/E ratio
-$0.04
EPS
0.97
Beta
-
Dividend rate
Price and volume
Market cap
$150M
Beta
0.97
Financial strength
Current ratio
11.497
Quick ratio
10.663
Long term debt to equity
0.715
Total debt to equity
1.08
Interest coverage (TTM)
-275.73%
Management effectiveness
Return on assets (TTM)
-8.23%
Return on equity (TTM)
-15.07%
Valuation
Price to revenue (TTM)
5.661
Price to book
0.63
Price to tangible book (TTM)
1.27
Price to free cash flow (TTM)
-4.566
Growth
Revenue change (TTM)
25.68%
Earnings per share change (TTM)
88.24%
3-year revenue growth (CAGR)
1,128.64%
3-year earnings per share growth (CAGR)
-26.00%
What the Analysts think about Zomedica
Analyst Ratings
Majority rating from 1 analysts.
Zomedica Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$6.2M
-15.07%
Net income
-$9.1M
-59.38%
Profit margin
-146.77%
-52.17%
Zomedica Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Actual
-$0.01
-$0.00
-$0.01
-$0.01
Expected
-
-
-
-
Surprise
-
-
-
-
Zomedica News
AllArticlesVideos
The United States Eventing Association Names Zomedica's PulseVet(R) as the Official Shock Wave of the USEA
Accesswire·1 week ago
Zomedica Expands Global Reach Through Strategic Alliance with Leader Healthcare Group for Sales Expansion in Key International Markets
Accesswire·3 weeks ago
US Equestrian Names Zomedica's PulseVet System as the Official Shock Wave Therapy of US Equestrian Team Veterinarians
Accesswire·4 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Zomedica stock?
Zomedica (ZOM) has a market cap of $150M as of July 27, 2024.
What is the P/E ratio for Zomedica stock?
The price to earnings (P/E) ratio for Zomedica (ZOM) stock is 0 as of July 27, 2024.
Does Zomedica stock pay dividends?
No, Zomedica (ZOM) stock does not pay dividends to its shareholders as of July 27, 2024.
When is the next Zomedica dividend payment date?
Zomedica (ZOM) stock does not pay dividends to its shareholders.
What is the beta indicator for Zomedica?
Zomedica (ZOM) has a beta rating of 0.97. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.
Buy or sell Zomedica stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.